Abstract:AIMS Endothelial cell (EC) homeostasis plays an important role in normal physiological cardiac functions, and its dysfunction significantly influences pathological cardiac remodeling after myocardial infarction (MI). It has been shown that the sphingosine 1-phospahte receptor 1 (S1pr1) was highly expressed in ECs and played an important role in maintaining endothelial functions. We thus hypothesized that the endothelial S1pr1 might be involved in post-MI cardiac remodeling. METHODS AND RESULTS Our study showed that the specific loss of endothelial S1pr1 exacerbated post-MI cardiac remodeling and worsened cardiac dysfunction. We found that the loss of endothelial S1pr1 significantly reduced Ly6clow macrophage accumulation, which is critical for the resolution of inflammation and cardiac healing following MI. The reduced reparative macrophages in post-MI myocardium contributed to the detrimental effects of endothelial S1pr1 deficiency on post-MI cardiac remodeling. Further investigations showed that the loss of endothelial S1pr1 reduced Ly6clow macrophage proliferation, while the pharmacological activation of S1pr1 enhanced Ly6clow macrophage proliferation and thereby ameliorated cardiac remodeling after MI. A mechanism study showed that S1P/S1pr1 activated the ERK signaling pathway and enhanced colony stimulating factor 1 (CSF1) expression, which promoted Ly6clow macrophage proliferation in a cell-contact manner. The blockade of CSF1 signaling reversed the enhancing effect of S1pr1 activation on Ly6clow macrophage proliferation and worsened post-MI cardiac remodeling. CONCLUSIONS This study reveals that cardiac microvascular endothelium promotes reparative macrophage proliferation in injured hearts via the S1P/S1PR1/ERK/CSF1 pathway and thus ameliorates post-MI adverse cardiac remodeling. TRANSLATIONAL PERSPECTIVE This study highlights the importance of the local vascular microenvironment in orchestrating tissue inflammation and remodeling by regulating self-replenishment of tissue local reparative macrophages. Our studies demonstrate that ECs tightly control post-MI reparative Mo/Mϕ proliferation via the S1P/S1PR1/CSF1 pathway in a cell-contact manner. This implies that a feasible modulation of vascular niche signals might provide a promising target to resolve excessive inflammation and to ameliorate adverse cardiac remodeling after MI.

Sphingosine-1-phosphate Signaling Pathway: a Novel Therapeutic Target for Cardiovascular Diseases

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics

Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases

Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

Sphingosine 1-phosphate and inflammation.

Sphingosine-1-phosphate: a Potential Therapeutic Target for Rheumatoid Arthritis

Vascular Endothelial S1pr1 Ameliorates Adverse Cardiac Remodelling Via Stimulating Reparative Macrophage Proliferation after Myocardial Infarction.

Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond

Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease

The Relationship Between the Apolipoprotein M-sphingosine-1-phosphate Axis and Atherosclerosis

High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?

Sphingosine 1-Phosphate Signaling Contributes to Cardiac Inflammation, Dysfunction, and Remodeling Following Myocardial Infarction.

Sphingosine 1-Phosphate, Sphingosine Kinase and Stroke

Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases

High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury in Vivo Via the S1P 3 Lysophospholipid Receptor

High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway: A POSSIBLE MECHANISM FOR PROTECTION AGAINST ATHEROSCLEROSIS BY HDL

Advances of Sphingosine-1-phosphate in Angiogenesis